ENHRX
Price
$10.44
Change
-$0.07 (-0.67%)
Updated
Sep 5 closing price
Net Assets
150.87M
GSFPX
Price
$18.22
Change
-$0.04 (-0.22%)
Updated
Sep 5 closing price
Net Assets
3.63B
Interact to see
Advertisement

ENHRX vs GSFPX

Header iconENHRX vs GSFPX Comparison
Open Charts ENHRX vs GSFPXBanner chart's image
Cullen Enhanced Equity Income Retail
Price$10.44
Change-$0.07 (-0.67%)
VolumeN/A
Net Assets150.87M
Goldman Sachs US Eq Div and Premium P
Price$18.22
Change-$0.04 (-0.22%)
VolumeN/A
Net Assets3.63B
ENHRX vs GSFPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ENHRX vs. GSFPX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENHRX is a Hold and GSFPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSFPX has more cash in the bank: 3.63B vs. ENHRX (151M). ENHRX pays higher dividends than GSFPX: ENHRX (5.63) vs GSFPX (1.15). ENHRX was incepted earlier than GSFPX: ENHRX (10 years) vs GSFPX (7 years). ENHRX (1.50) is less costly to investors than GSFPX (0.74). ENHRX is a more actively managed with annual turnover of: 125.00 vs. GSFPX (23.00). GSFPX has a lower initial minimum investment than ENHRX: GSFPX (0) vs ENHRX (1000). GSFPX annual gain was more profitable for investors over the last year : 9.66 vs. ENHRX (2.98). ENHRX return over 5 years is better than : 45.33 vs. GSFPX (41.29).
ENHRXGSFPXENHRX / GSFPX
Total Expense Ratio1.000.68147%
Annual Report Gross Expense Ratio1.500.74203%
Fund Existence10 years7 years-
Gain YTD5.6867.93472%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets151M3.63B4%
Annual Yield % from dividends5.631.15489%
Returns for 1 year2.989.6631%
Returns for 3 years21.4736.7658%
Returns for 5 years45.3341.29110%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACWZX19.340.15
+0.78%
AMG GW&K Small/Mid Cap Growth Z
TGCNX25.550.01
+0.04%
TCW Concentrated Large Cap Growth N Cl
TNBRX20.51-0.04
-0.17%
1290 SmartBeta Equity R
LAVYX16.81-0.05
-0.30%
Lord Abbett Fundamental Equity I
JVAQX40.54-0.13
-0.32%
JPMorgan Value Advantage R4